National Survey and Case-vignette Study of Clinical Decisions in Pancreatic Cancer
GECP01
1 other identifier
observational
69
1 country
1
Brief Summary
Very few surveys have been carried out about oncosurgical decisions made in patients with pancreatic cancer (PC), and none have established whether the therapeutic approaches differ between low/medium and high volume centers. A survey was sent out to centers from Spanish Group of Pancreatic Surgery (GECP) asking about usual pre, intra and postoperative management of PC patients and describing five imaginary cases of PC corresponding to common scenarios that surgeons regularly assess in oncosurgical meetings. Investigators define consensus when 80% of answers were equal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedFirst Submitted
Initial submission to the registry
January 15, 2021
CompletedFirst Posted
Study publicly available on registry
February 15, 2021
CompletedFebruary 15, 2021
February 1, 2021
11 months
January 15, 2021
February 11, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Measurement of consensus in therapeutical decisions in pancreatic cancer between low/mid vs high volume hospitals
Percentage of consensus in therapeutical decisions. Difference (p\<0.05) (if exists) between high and low volume centers
Survey sent in 2020. Time to receive surveys up to 12 weeks
Interventions
We sent a survey and case vignette cases to every responsible in each center
Eligibility Criteria
Surgeons responsible of GECP in each center
You may qualify if:
- Resposnible for each center of GECP
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Miguel Servetlead
- Hospital General Universitario de Alicantecollaborator
Study Sites (1)
Jose M Ramia
Alicante, 03016, Spain
Related Publications (1)
Ramia JM, Cugat E, De la Plaza R, Gomez-Bravo MA, Martin E, Munoz-Bellvis L, Padillo FJ, Sabater L, Serradilla-Martin M. Clinical decisions in pancreatic cancer surgery: a national survey and case-vignette study. Updates Surg. 2023 Jan;75(1):115-131. doi: 10.1007/s13304-022-01415-1. Epub 2022 Nov 14.
PMID: 36376560DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jose Ramia, PhD
Hospital General Universitario de Alicante
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Consultant in Department of Surgery
Study Record Dates
First Submitted
January 15, 2021
First Posted
February 15, 2021
Study Start
January 1, 2020
Primary Completion
November 30, 2020
Study Completion
December 31, 2020
Last Updated
February 15, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share